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Abstract
Purpose The effectiveness of vertebral augmentation tech-
niques is a currently highly debated issue. The biomechanical
literature suggests that cement filling volumes may play an
important role in the ‘‘dosage’’ of vertebral augmentation and
its pain alleviating effect. Good clinical data about filling
volumes are scarce and most patient series are small. There-
fore, we investigated the predictors of pain alleviation after
balloon kyphoplasty in the nationwide SWISSspine registry
where cement volumes are also recorded.
Methods All single-level vertebral fractures with no addi-
tional fracture stabilization and availability of at least one
follow-up within 6 months after surgery were included. The
following potential predictors were assessed in a multivari-
ate logistic regression model with the group’s average pain
alleviation of 41 points on VAS as the desired outcome:
patient age, patient sex, diagnosis, preoperative pain, level of
fracture, type of fracture, age of fracture, segmental kyphotic
deformity, cement volume, vertebral body filling volume,
and cement extrusions.
Results There were 194 female and 82 males with an
average age of 70.4 and 65.3 years, respectively. Female
patients were about twice as likely for achieving the
average pain relief compared to males (p = 0.04). The
preoperative pain level was the strongest predictor in that
the likelihood for achieving an at least 41-point pain relief
increased by about 8 % with each additional point of pre-
operative pain (p \ 0.001). A thoraco-lumbar fracture had
a three times higher odds for the average pain relief com-
pared with a lumbar fracture (p = 0.03). An A.3.1 fracture
only had about a third of the probability for average pain
relief compared with an A.1.1 fracture (p = 0.004).
Cement volumes up to 4.5 ml only had an approximately
40 % chance for a minimum 41-point pain alleviation as
compared with cement volumes of at least 4.5 ml
(p = 0.007). In addition, the relationship between cement
volume and pain alleviation followed a dose-dependent
pattern.
Conclusions Cement volume was revealed as a signifi-
cant predictor for pain relief in BKP. Cement volume was
the third most important influential covariate and the most
important modifiable and operator dependent one. The
clear dose-outcome relationship between cement filling
volumes and pain relief additionally supports these find-
ings. Cement volumes of [4.5 ml seem to be recom-
mendable for achieving relevant pain alleviation. Patient
sex and fracture type and location were further significant
predictors and all these covariates should be recorded and
reported in future studies about the pain alleviating effec-
tiveness of vertebral augmentation procedures.
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Introduction
One of the currently highly debated issues in spinal surgery
is the effectiveness of vertebral augmentation techniques
such as vertebroplasty (VP) or balloon kyphoplasty (BKP).
Both surgical procedures are applied for treatment of
osteoporotic vertebral fractures with the goal of relieving
pain and realigning the fractured vertebral body to some
extent. During VP bone cement is percutaneously injected
into a fractured vertebra to stabilize it, which is the main
goal of the procedure. Kyphoplasty is a variation of VP that
attempts to achieve more realignment and less cement
extrusion by creating a void with an expandable balloon
that is filled with bone cement after balloon removal. Both
procedures, however, aim at an immediate and clinically
relevant pain relief as their main goal.
The two investigations [1, 2] comparing VP to ‘‘sham’’
operations published in the New England Journal of
Medicine (NEJM) indicated that VP is no more effective
than injection of local anaesthetic at the pedicle entry site,
i.e., a facet joint infiltration. In view of the widespread use
of vertebral augmentation techniques, their newly ques-
tioned effectiveness has already had implications for clin-
ical guidelines and reimbursement policies.
Other authors have meanwhile pointed out that these
findings are clearly at odds with the previously published
clinical investigations which indicate a significant clinical
benefit of vertebral augmentation procedures, such as
vertebro- and kyphoplasty over conservative treatment
[3, 4]. In addition, new RCTs like the Vertos II trial confirm
the results from observational studies [5]. This discrepancy
can only reasonably have two explanations: the placebo
effect has been severely underestimated in previously
published investigations or the application of the vertebral
augmentation was insufficient compared to other studies.
The very basic foundation of any RCT is to ensure that all
patients in the treatment arm have actually received the
treatment in a manner that may be presumed to be effec-
tive, a fact that we propose to refer to as ‘‘clinical validity’’.
VP is a complex procedure to investigate with an RCT as
there are considerable variables in conducting the actual
procedure. Besides the technique of insertion of the
delivery needle, the injection or dosage of the ‘‘active
agent’’—generally, polymethylmethacrylate (PMMA)—is
modifiable to a great extent and entirely operator depen-
dent. The instillation of PMMA into the fractured vertebral
body improves the mechanical properties and is presumed
to provide pain relief by reducing painful loading and
abnormal micromotion. Clearly, a minimal amount of
PMMA will have no appreciable effect and likewise an
excessive amount hardens the vertebral body beyond
its original state and may have an adverse effect on
adjacent osteoporotic vertebrae and additionally cause
extravasations. Boszczyk [6] has summarized biomechan-
ical data demonstrating that a minimum necessary cement
volume is required for achieving an appreciable biome-
chanical effect. At the same time, the information about
filling volumes in the two NEJM RCTs was either
incomplete, insufficiently detailed or pointed at filling
volumes that were too small for reaching the above-
described biomechanical stabilization of the treated VBs in
the lower thoracic and lumbar spine.
Large observational studies like registries documenting
numerous covariates and representing the ‘‘natural dosing’’
of a surgical intervention in the day-to-day clinical setting
represent excellent possibilities for analyzing procedural or
patient characteristics with an influence on the outcome
[7]. Since 2005, BKP procedures and outcomes have been
documented in a government mandated Swiss nationwide
registry. The setup and details of ‘‘SWISSspine’’ have
previously been published [8]. The current study hypoth-
esized that cement volume had a significant influence on
pain alleviation after BKP.
Materials and methods
Initiated in March 2005, the SWISSspine registry is
ongoing to the present. Following the principle of ‘‘cov-
erage with evidence generation’’ its purpose is to provide
evidence of the safety and what Archie Cochrane described
as ‘‘efficiency’’ of BKP, that is, its performance in the
clinical setting [9]. This term is nowadays rather referred to
as ‘‘effectiveness’’, being high on external validity but at
the expense of internal validity like, for example, careful
controls. The Institute for Evaluative Research in Medicine
at the University of Bern (IEFM), an international leader in
the field of registry implementation, was mandated to serve
as technology provider and organizer of the SWISSspine
registry. Documentation forms and outcome instruments
that are used for the BKP arm of the SWISSspine registry
are the following:
1. Primary intervention form (surgeon administered),
2. Follow-up form (surgeon administered),
3. Euroqol-5D (EQ-5D) general Quality of Life (QoL)
form (patient assessment),
4. North American Spine Society disease specific
(NASS) QoL form (patient assessment) with VAS,
5. Comorbidity questionnaire (patient assessment),
6. Two patient consent forms (one remains at the
treatment center and one at IEFM),
7. One annotation form about the registry and its purpose
(also signed by patient).
At the time of surgery, the primary intervention form is
completed by the surgeon. Informed consent about
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participation in the registry has to be given by the patient as
well as completed EQ-5D, NASS, and comorbidity ques-
tionnaires. During follow-ups at 3 months, 1 year, and
annually thereafter, questionnaires are completed by the
surgeon. Patients are again asked to complete the EQ-5D
and NASS questionnaires.
Inclusion criteria
Inclusion criteria for the analysis were a single-level verte-
bral fracture treated with BKP and no additional fracture
stabilization, and availability of at least one follow-up within
6 months after surgery. Pre- and postoperative information
documented by the surgeon and information about disease
specific quality of life (NASS incl. pain VAS) as recorded by
the patient needed to be available for feeding these covariates
into the multivariate logistic regression. The group‘s average
back pain alleviation of 41 points on VAS 0-100 was used as
the success or failure criterion. Influence of the following






• Level of fracture
• Type of fracture
• Age of fracture
• Segmental kyphosis angle
• Cement volume
• VB filling volume
• Extrusions
Patient age was used as a continuous and sex as a cat-
egorized variable. Based on previous findings presence or
absence of a pharmacologically treated depression or pre-
operative general quality of life (EQ-5D score) was not
included in the model [8]. The level of the monosegmen-
tal fracture or rather localization of the treatment was
categorized into three groups: (1) thoracic vertebral
bodies Th4–Th10, (2) thoraco-lumbar vertebrae Th11–L2,
(3) lumbar vertebrae L3–L5. Fracture types were catego-
rized as A.1.1, A.1.2, A.3.1 or other. Preoperative
segmental kyphotic angles were categorized according to
the SWISSspine BKP forms into none, 10–15, 16–20,
21–25, 26–30, [30. Fracture age was detailed as less
or more than 8 weeks since onset of symptoms. Cement
extrusions were recorded as present or not present, inde-
pendent of direction of extrusion or several extrusions from
one and the same fracture site. Cement volumes were
categorized according to the SWISSspine BKP case report
forms into \3, 3–4.5, 4.6–6, 6.1–7.5, and [7.5 ml but for
the final model they were converted into a binary format
with B4.5 and[4.5 ml. Vertebral body filling volumes (%)
were calculated in a sex and level adjusted way by using
the mean values of the above mentioned cement volume
categories (1.5, 3.75, 5.3, 6.8, 9 ml) and dividing them
by the respective vertebral body volumes published by
Limthongkul et al. [10].
Statistical analysis
A multivariate logistic regression model was built with
pain alleviation greater or smaller than 41 points on VAS
as the outcome. The above-described covariates were fed
into the model and the significant ones were identified with
backward elimination. The level of significance was set to
a = 0.05. All statistical analyses were conducted using
SAS 9.2 (SAS Institute Inc, Cary, NC, USA).
Results
Patient characteristics
There were 194 female and 82 male with an average age of
70.4 and 65.3 years, respectively. 61 % of cases were
treated for an osteoporotic fracture, 36.4 % for a traumatic
one, and 2.6 % for a lytic fracture. Stratified by sex, 68.3 %
of women had an osteoporotic fracture, 29.1 % a traumatic
one and 2.6 % a lytic fracture. In men the distribution was
43.8, 53.8 and 2.4 %, respectively. The average follow-up
time was 106 days. Mean preoperative pain level was 69.3
points on VAS 0–100, the postoperative one was 28.7.
Stratified by sex mean preoperative pain levels were 71
(female) and 65.2 (male) points. The mean postoperative
pain levels were 27.1 (female) and 32.4 (male) points.
Cement volumes between 3 and 6 ml were predominantly
used in the thoracic spine, those between 4.6 and 6 ml in
the thoraco-lumbar junction, and those [7.5 ml in the
lumbar spine (Fig. 1). Overall distribution of cement vol-
ume categories with extrusion and fracture type rates are
shown in Fig. 2. Mean vertebral body filling volumes were
22.1 % (min 5.1 %, max 44.3 %) with one outlier having
received 9 ml of cement with a filling volume of 56.3 %
(Fig. 3). There were cement extrusions in a total of 27.2 %
of cases. 10.6 % of fractures were located between Th4 and
10, 71.8 % between Th11 and L2, and 17.6 % between L3
and L5. There were 200 fractures treated earlier than
8 weeks after their occurrence, and 76 treated later than
8 weeks.
Predictors for pain alleviation of at least 41 VAS points
While patient age did not have a significant influence on
achieving the average pain relief of 41 points, patient sex
Eur Spine J (2013) 22:2241–2248 2243
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did. Female patients were about twice as likely for
achieving this amount of pain relief compared to males
(p = 0.04). The preoperative pain level was the strongest
predictor in that the likelihood for achieving an at least 41
point pain relief increased by about 8 % with each addi-
tional point of preoperative pain (p \ 0.001) (Table 1).
Fracture characteristics
The location of fracture, simplified as thoracic, thoraco-
lumbar or lumbar, and the fracture type both had an
influence on pain relief. A thoraco-lumbar fracture had an
about three times higher likelihood for achieving the
average pain relief compared with a lumbar fracture
(p = 0.03), and an A.3.1 fracture did only have about a
third of the probability compared with an A.1.1 fracture
(p = 0.004). The fracture etiology and vertebral body
fracture deformation, expressed as segmental kyphotic
angle, did not have a significant influence, neither did
fracture age (Table 1).
Operator-dependent covariates
A cement extrusion did not influence the odds for achiev-
ing the average pain relief. Cement volume, however, did.
Volumes up to 4.5 ml only had an approximately 40 %
chance for a minimum 41 point pain alleviation as com-
pared with cement volumes of more than 4.5 ml
(p = 0.009) (Table 1). The relationship between cement
volume and pain alleviation followed a dose-dependent
Fig. 1 Distribution of cement volume categories across three spinal levels
Fig. 2 Overall distribution of cement volume categories and related extrusion and fracture type rates. ‘‘Other’’ fracture types not shown
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pattern as illustrated in Table 2. The percentage of patients
with a pain relief of at least 41 points increased from 20 to
68.1 % in proportion with the increase in cement volume
up to 7.5 ml. Also, mean and median pain alleviation levels
increased with each cement volume category and were the
highest in the volume class of 6–7.5 ml. Cement volumes
between 4.5 and 7.5 ml seem to be the ideal filling volumes
for pain alleviation in BKP. Finally, vertebral body filling
volumes did not have a significant influence on pain relief,
neither as a continuous nor as a categorized covariate.
Discussion
The hypothesis of the current study was confirmed and
cement volume was revealed as a significant predictor for
pain relief in BKP. With the exception of the preoperative
pain level of the patient and the fracture type, cement
volume was the third most important influential covariate
and the most important modifiable and operator-dependent
one. The clear dose–outcome relationship between cement
filling volumes and pain relief additionally supports these
findings.
Patient sex was another patient characteristic signifi-
cantly influencing postoperative pain levels. Fracture spe-
cific predictors for pain relief were fracture type and
fracture location. Patient age, fracture age and etiology,
segmental kyphotic deformity, cement filling volume, and
presence or absence of extrusions did not significantly
influence pain relief.
To the best of our knowledge this is the first study
revealing cement volume as a significant covariate in the
complex interplay of factors that may or may not lead to
clinically relevant pain relief after vertebral augmentation
with BKP. Only one other study investigated on this issue
and concluded that ‘‘pain and disability scores improved
pre- to posttreatment, even were low cement volumes are
used’’. This study by Ioannou et al. [11], did, however, only
investigate on 20 patients and focused on the significance
of pre- to postoperative pain relief, and not, as the current
study did, on the probability for reaching what could be
considered the benchmark of pain relief, i.e., the average
pain alleviation of a large patient sample. The preoperative
kyphosis, representing the extent of fracture related verte-
bral body deformation, may intuitively be considered as an
important factor determining the amount of injectable
cement volume and therefore influencing the interplay
between absolute cement volume and pain relief, but it
could not be revealed as a significant predictor with our
data. This may also have to do with only the segmental
kyphosis being available for analysis, whereas the local
kyphosis would have been the more precise measure.
Fig. 3 Distribution of approximated cement filling volumes,
adjusted for sex and spinal level
Table 1 Possible predictors for pain alleviation of at least 41 VAS
points in BKP
Predictor p value OR 95 % CI
Age of patient 0.27 n.s n.a.






\0.001* 1.08 per additional
preoperative point on VAS
1.06–1.10
Fracture type 0.004* 0.23: A.3.1 vs A.1.1 0.07–0.74
Fracture age 0.31 n.s n.a.
Fracture
location














n.s. not significant, n.a. not applicable
* Significant predictor


















\3 0.03 27 35 20
3–4.5 23.1 40 40 46.8
4.6–6 30.6 40 50 53.7
6.1–7.5 17.5 50 60 68.1
[7.5 25 37 40 47.8
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Instead, fracture location and to an even more significant
extent fracture type are further predictors for pain relief.
We could not find any article investigating the role of the
spinal level in BKP pain relief but static and load issues are
the most probable explanations why lumbar VBs had less
BKP benefits than thoraco-lumbar ones. Finally, the less
traumatic cranial endplate impression fractures (A.1.1)
seem to have a significantly better prognosis regarding pain
relief than cranial burst fractures (A.3.1) and the influence
of fracture type on pain may overshadow that of the pre-
operative local kyphosis or vertebral body filling volume.
The literature is also scarce regarding this topic but
remaining instability after burst fracture or cement rather
distributing between the fracture parts instead within them
may be possible explanations.
Most other studies focused on the role of cement volume
in VP and the large majority of them dealt with mechanical
behavior, stiffness and stress distribution. Despite its sub-
title ‘‘Only Small Cement Volumes Are Required to Nor-
malize Stress Distributions on the Vertebral Bodies’’, Luo
et al. [12] concluded that ‘‘3.5 ml of PMMA largely
restored normal stress distributions to fractured and adja-
cent vertebral bodies, but 7 ml were required to restore
motion segment stiffness and load-sharing between the
vertebral bodies and neural arch’’. Molloy et al. [13]
applied cement volumes between 2 and 8 ml and found
weak correlations between percentage of fill and restored
strength and stiffness. On average, restoration of strength
and stiffness required vertebral body cement fills of 16.2
and 29.8 %, respectively. Finally, Liebschner et al. devel-
oped a finite element model of L1, filled it with volumes
between 1 and 7 ml and showed that only a small amount
of bone cement (14 % fill or 3.5 cm3) was necessary to
restore stiffness of the damaged vertebral body to the
predamaged value. Use of a 30 % fill increased stiffness by
more than 50 % compared with the predamaged value. He
concluded that greater filling can result in substantial
increase in stiffness well beyond the intact level. Such
overfilling also renders the system more sensitive to the
placement of the cement because asymmetric distributions
with large fills can promote single-sided load transfer [14].
Looking at the approximated mean filling volume of
22.1 % in the current study, real life vertebral body filling
volumes with BKP were well within those researched in
biomechanical experiments and models. Despite minimum
levels going down to 5 %, the normal distribution of the
cement filling volume curve was probably responsible for
this covariate not becoming a significant predictor for pain
relief.
The literature about outcome predictors for BKP is
scarce and rather focuses on preoperative diagnostics and
patient selection in a sense that cases with a bone edema
detectable on MRI or scintigraphy were experiencing very
good pain relief [15, 16]. Investigations for VP are more
numerous. Alvarez was the first author to look for predic-
tors of outcome of percutaneous VP in the clinical setting.
He retrospectively analyzed his own series of 278 cases
and found ASA score and extent of vertebral body height
loss to be significant predictors for clinical success in a
multivariate regression analysis [17]. Kaufmann et al.
retrospectively looked at clinical outcomes of 158 cases
from 1 week up to 2 years after surgery and concluded that
there was no significant association between the volume of
cement injected and the clinical outcomes for post-proce-
dure pain and medication use. VP surgeons need not feel
compelled to achieve particular cement volumes injected in
the pursuit of better clinical outcomes, but should strive to
achieve the maximal safe filling of individual vertebral
bodies [18]. Alvarez included single and multilevel cases
which does add statistical complexity to the predictor
search and Kaufmann used cement volume as a continuous
covariate instead of a categorized one, as we had to do. In
addition, there were not too many cases with really low
cement volumes in his sample. This makes it more difficult
to find significance in relation with the primary outcome
parameter or to find an exact threshold level for a clinically
effective cement volume.
Kaufmann did not find associations between cement
filling volume and likelihood for cement extrusions in VP
[18]. Ren et al. [19], however, revealed cement volume and
vertebral wall incompetence as significant predictors for
cement leakage in BKP in their multivariate model of 171
vertebral bodies. In our study, extrusion rates varied
between 22 and 30 % in the different volume categories
and a separate analysis on the same monosegmental sample
(submitted for publication) revealed patient sex as highly
significant and cement volume as borderline significant
leakage predictor. Women were more likely to show
leakage and cement volumes above 4.5 ml were more
likely than volumes below 4.5 ml. The probably most
influential factor on leakage, cement viscosity, had not
been assessed in any of the above cited studies and was not
recorded on the SWISSspine forms. It seems, however, of
more interest in VP where the use of highly viscous
cements leads to lower extrusion rates comparable with
those of BKP [20]. This was previously confirmed by
Rapan et al. and Anselmetti et al. [21, 22] who found
significantly less extravasations and related complications
in patients treated with high viscous cement.
Aspired cement volumes need to be put in relation to the
volumes of vertebral bodies which increase the more cau-
dally they are located (31 % L3–5 fractures in volume
category [7.5 ml) and the type of fracture may also have
an influence (33.3 % A3.1 fractures in volume category
[7.5 ml). However, the overall distribution of vertebral
body filling volumes was very homogeneous.
2246 Eur Spine J (2013) 22:2241–2248
123
Weaknesses and strengths
SWISSspine is an observational study which was not
designed for the current analysis and did not have any data
monitoring and validation mechanisms. On the other hand,
the crudeness of the cement volume categories may result in
relatively reliable estimates and there was no obvious reason
for the surgeons to document them in a dishonest manner.
The real life nationwide setting and the large number of
patients and health care providers contributing data to the
SWISSspine data pool increase the external validity of our
findings with an admittably limited internal validity. Reg-
istry data help in generating hypotheses which need to be
challenged in more controlled study designs if possible.
Conclusion
Cement volume was revealed as a significant modifiable
predictor for pain alleviation in BKP. However, instead of
striving for maximum filling volumes, surgeons need to be
aware of the increased risk of cement extrusions. Cement
types with higher viscosity may help apply the procedure
with a sufficiently high ‘‘dosage’’ without increasing harm
for the patient. Cement volumes [4.5 ml seem to be rec-
ommendable for achieving relevant pain alleviation.
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